Skip to main content
logo
Esperion Therapeutics, Inc. (ESPR)
Jul 13, 2026 - ESPR was delisted
3.180
-0.010 (-0.31%)
Inactive · Last trade price on Jul 10, 2026

Esperion Therapeutics Revenue

Esperion Therapeutics had revenue of $80.10M in the quarter ending March 31, 2026, with 23.25% growth. This brings the company's revenue in the last twelve months to $418.24M, up 61.13% year-over-year. In the year 2025, Esperion Therapeutics had annual revenue of $403.14M with 21.31% growth.

Revenue (ttm)
$418.24M
Revenue Growth
+61.13%
P/S Ratio
1.96
Revenue / Employee
$1,422,599
Employees
294
Market Cap
819.46M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025403.14M70.82M21.31%
Dec 31, 2024332.31M215.98M185.66%
Dec 31, 2023116.33M40.86M54.14%
Dec 31, 202275.48M-2.97M-3.79%
Dec 31, 202178.45M-149.10M-65.52%
Dec 31, 2020227.55M79.18M53.37%
Dec 31, 2019148.36M--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ESPR News

More News